Internship

Medical / Digital Health Working Student

Cara Care

Cara Care

51-200 employees

Digital therapeutics platform for digestive health

No salary listed

Remote in Germany + 1 more

More locations: Berlin, Germany

Remote

Category
Biology & Biotech
Required Skills
Python
R

Get referred to Cara Care

See people who can refer or advise you

Requirements
  • You must be enrolled in a study program and be at least in your third semester, ideally in Human Medicine, Health Sciences, Psychology, Public Health, Nutritional Sciences, or a comparable program.
  • You must be interested in evidence-based medicine, clinical research, and digital health applications.
  • You must be able to read, understand, write, and concisely summarize scientific texts in German and English.
  • You must work carefully, systematically, and reliably, particularly with sources, references, and formal requirements.
  • You must speak German at native-speaker level and have very good written and spoken English.
  • You must have knowledge of study methodology and statistics, R, or Python.
Responsibilities
  • Conduct literature and evidence searches in scientific databases, guidelines, and other reliable sources.
  • Review, summarize, and prepare studies, guidelines, and medical specialist information.
  • Maintain, verify, and format bibliographies and support citation management.
  • Support medical-scientific, patient-centered, and digital care concepts.
  • Research medical, care-related, and regulatory questions in the Digital Health field.
  • Contribute to presentations, internal documentation, scientific manuscripts, and research projects.
  • Support the development and revision of evidence-based content for digital interventions and patient communication.
Desired Qualifications
  • Initial experience with PubMed, Google Scholar, the Cochrane Library, or Zotero is desirable.

Cara Care builds a mobile app that delivers a personalized, multi-therapy program for digestive conditions like IBS, IBD, and GERD. The app combines nutritional therapy, care from certified psychologists, and a digital diary to track symptoms, diet, and well-being, guiding users through individualized plans that adapt over time. In Germany the program is a DiGA prescription medical device reimbursed by statutory health insurances, and the company also offers a US version, supported by investor funding and clinical studies validating its effectiveness. Its goal is to improve access to evidence-based digestive care and support long-term symptom management, while expanding internationally and continuing clinical validation.

Company Size

51-200

Company Stage

Early VC

Total Funding

$17.4M

Headquarters

Berlin, Germany

Founded

2016

Get referred to Cara Care

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Permanent German reimbursement supports recurring prescription volume and defensible payer access.
  • Mahana says thousands of German patients already use Cara Care's reimbursed IBS program.
  • The Mahana platform now sells across the United States, Germany, and the United Kingdom.

What critics are saying

  • HiDoc entered self-administration insolvency on September 23, 2024, signaling weak standalone economics.
  • Bayer announced a competing Cara Care acquisition plan in December 2024, creating transaction risk.
  • Oshi Health, Bold Health, and Cylinder attack the same digestive care market in 2026.

What makes Cara Care unique

  • Mahana owns Cara Care since March 12, 2024, combining digestive digital therapeutics globally.
  • Cara Care holds permanent German reimbursement for IBS since June 11, 2024.
  • Its program pairs CBT, nutrition, and symptom tracking for GI disease patients.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Flexible Work Hours

Paid Vacation

Mental Health Support

Growth & Insights and Company News

Headcount

6 month growth

↓ -3%

1 year growth

↓ -3%

2 year growth

↓ -3%
DigitalFoodLab
Mar 26th, 2024
10 notable deals and things to know this week (2024 - week #13)

Cara Care, a Germany-based startup developing a digital platform to manage digestive health conditions such as IBS, was acquired by Mana Therapeutics, a US-based company.

Mahana Therapeutics
Mar 13th, 2024
Mahana Therapeutics Acquires Cara Care to Become a Global Leader in the Digital Treatment of Chronic Conditions | Mahana Therapeutics

‍SAN FRANCISCO, USA – March 12, 2024 – Mahana Therapeutics, a leading provider of digital chronic condition management programs, announced today that it has acquired Berlin-based HiDoc Technologies GmbH, operating as Cara Care, a leader in digital digestive healthcare. This combination creates a global company offering the most comprehensive digestive health portfolio currently addressing Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD), Celiac Disease and Heartburn, with an exciting pipeline focused on Tinnitus, Pruritus, and Vulvodynia.

Tech.eu
Mar 12th, 2024
Mahana Therapeutics acquires Berlin's Cara Care, expanding digital treatment for chronic conditions

Mahana Therapeutics acquires Berlin's Cara Care, expanding digital treatment for chronic conditions.

Business Wire
Mar 12th, 2024
Mahana Therapeutics Acquires Cara Care to Become a Global Leader in the Digital Treatment of Chronic Conditions

Mahana Therapeutics acquires Cara Care to become a global leader in the digital treatment of chronic conditions.

EU-Startups
Jun 13th, 2022
Berlin-Based Cara Care Lands €6.6 Million For Its Digital Digestive Healthcare App

Digestive health issues are an increasingly common struggle for people across the world. It’s something that many silently suffer and don’t receive adequate care for. Cara Care is on a mission to change this giving everyone access to digestive healthcare via their phones and they’ve just cored €6.6 million.  With a commitment to holistic [] The post Berlin-based Cara Care lands €6.6 million for its digital digestive healthcare app appeared first on EU-Startups.